Back to results
US 2023/0028523 A1Published application
Lipophosphonoxins, their preparation and use
AssigneesUstav Organicke Chemie A Biochemie Av Cr, V. V. I., Mikrobiologicky Ustav Av Cr, V. V. I., Univerzita Palackeho V Olomouci
InventorsDominik REJMAN, Radek POHL, Viktor MOJR, Duy Dinh DO PHAM, Milan KOLAR, Libor KRASNY
Life of this patent
Estimating the term…
Abstract
Lipophosphonoxins of general formula I, diastereomers and mixtures of diastereomers of compounds of general formula I and their pharmaceutically acceptable salts and hydrates as antibacterial agents, forming an active ingredient in pharmaceutical compositions for the treatment of resistant bacterial infections, disinfectants and/or selective culture media is disclosed.
Claims9
Lipopolyphosphonoxin of the general formula I
- wherein:
- the X substituent is independently selected from the following structures:
- wherein m=1-3;
- the Y substituent is independently selected from the following structures:
- wherein n=0-12, and o=0-12, and p=0-12, and
- R1, R2, R3, R4, and R5 are independently selected from the group consisting of:
- H-, CH3-, CH2CH3, propyl, isopropyl, isobutyl, tert-butyl, CH3O—, CH2CH3O—, propoxy, isopropoxy, isobutyloxy or tert-butyloxy;
- and
- the Z substituent is selected from the following structures:
- wherein q=2-14, and r=0-10, and s=0-10,
- or a diastereomer or a mixture of diastereomers of the compound of formula I, or a pharmaceutically acceptable salt or hydrate thereof.
8 more elements
Dependencies are inferred from the claim text.